WAS, WASP actin nucleation promoting factor, 7454

N. diseases: 204; N. variants: 37
Disease: Multiple Sclerosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis 		0.050 Biomarker disease BEFREE Plant-derived tetrahydrocannabinol/cannabidiol (THC/CBD) oromucosal spray is approved for spasticity in multiple sclerosis refractory to conventional treatment in 21 EFIC chapters. 29134767 2018
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis 		0.050 Biomarker disease BEFREE We aimed to assess the potential relationship between intrasubject 9-tetrahydrocannabinol/cannabidiol (THC/CBD) oromucosal spray plasma profiles and clinical effects elicited by subacute dosing in chronically treated patients with multiple sclerosis (MS). 30024443 2018
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis 		0.050 Biomarker disease BEFREE The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity. 29761015 2018
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis 		0.050 Biomarker disease BEFREE Cannabinoids such as <sup>9</sup>Δ-THC and CBD are multi-target compounds already introduced in the clinical practice for multiple sclerosis (MS). 29495967 2018
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis 		0.050 Biomarker disease BEFREE Second-line therapy includes add-on THC:CBD spray for patients with resistant MS spasticity. 30235965 2018